HOME >> MEDICINE >> NEWS
New edition of medical reference book provides the latest in hematology

(WASHINGTON, May 2, 2007) Just released, the third edition of the ASHTM Self-Assessment Program (ASH-SAP) is a comprehensive educational resource from the American Society of Hematology designed to help hematologists, oncologists, internists, pediatricians, and fellows in training stay current with the latest advancements in the rapidly evolving disciplines of adult and pediatric hematology and oncology.

The printed third edition and companion Web site offer a new chapter on plasma cell dyscrasias, up-to-date clinical vignettes, and a self-assessment test with more than 200 case-based, multiple-choice questions and critiques.

Completion of the ASH-SAP provides thorough board and recertification preparation and 50 AMA PRA Category 1 CreditsTM. In addition, a Maintenance of Certification (MOC) version of the program, the ASH-SAP/MOC, offers the opportunity to earn 70 medical knowledge points toward recertification through the American Board of Internal Medicine (ABIM). In order to support physicians enrolled in MOC, upon request ASH will provide a free copy of the ASH-SAP/MOC to recertifying hematologists whose certification expires now through 2010.

In addition, through a generous educational grant from Amgen, ASH is providing complimentary copies of the ASH-SAP to all U.S. and Canadian fellows in hematology, hematology/oncology, pediatric hematology/oncology, transfusion medicine, hematology-pathology, and oncology programs to help them further their education.

More information about the ASH-SAP is available at www.ash-sap.org. Questions may be directed to cme@hematology.org or 202-776-0544.


'"/>

Contact: Laura Stark
lstark@hematology.org
202-552-4914
American Society of Hematology
2-May-2007


Page: 1

Related medicine news :

1. ACP publishes Medicine in Quotations, second edition
2. Test project of patient-centered medical home model endorsed by American College of Physicians
3. Heroes of Chemistry honored for medical, energy, environmental breakthroughs
4. Refusal of medical and surgical interventions common among chronically ill elderly
5. W.M. Keck Foundation announces 2007 class of Distinguished Young Scholars in medical research
6. When minority patients have insurance and a medical home, their health care improves
7. Extended duration work shifts risky to the safety, well-being of medical interns, patients
8. Students with medical-related majors more likely to have poor quality sleep
9. Brightening prospects of using fluorescent nanotubes in medical applications
10. World first medical treatment announced by researchers
11. The general public lacks basic medical knowledge

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: New edition medical reference book provides the latest hematology

(Date:1/22/2015)... Angelweddingdress is a famous wedding dress company ... to follow it on Facebook, Twitter, and Pinterest. The fans ... Angelweddingdress draws a lottery every week. , Moreover, the company ... 2015. Click Angelweddingdress homepage for more information. ...
(Date:1/22/2015)... January 23, 2015 AngelWeddingDress, the premier ... 2015 maternity wedding dresses. View website of ... looking for maternity wedding dresses online for a bridal ... with high quality for them. Its maternity wedding dresses ...
(Date:1/22/2015)... Juvent Sports ( http://www.juventsports.com ) and ... Merchandise Show to bestow a Juvent Sports Achievement award ... Arlene McKitrick. The award commemorated and congratulated McKitrick for ... She won her first amateur tournament in 1979 and ...
(Date:1/22/2015)... January 22, 2015 Thousand of GranuFlo ... Care recalled its GranuFlo and NaturaLyte dialysis concentrates continue ... in U.S. District Court, District of Massachusetts, Bernstein Liebhard ... the Court has remanded a case filed by the ...
(Date:1/22/2015)... over 20 years, Dr. David Cruz of Cruz Chiropractic Care ... just about every type of injury that can result from car ... twenty-plus years, the team at Doctors on Liens has ... doctor. With the combined breadth of experience between the ...
Breaking Medicine News(10 mins):Health News:Angelweddingdress Invites Its Customers To Follow It On Facebook, Twitter, And Pinterest 2Health News:AngelWeddingDress Has Recently Released Its Collection Of 2015 Maternity Wedding Dresses 2Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 2Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 3Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 2Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 3Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 4Health News:Industry Leading Chiropractor in Oceanside Joins the Doctors on Liens Network 2
(Date:1/23/2015)... , Jan. 23, 2015 /PRNewswire/-- Harwood Feffer LLP ( www.hfesq.com ... directors of Advaxis, Inc. ("Advaxis" or the "Company") (NASDAQ: ... breached its fiduciary duties to shareholders. On ... investing website reporting that Advaxis had misrepresented the clinical ...
(Date:1/23/2015)... Jan. 23, 2015  Lixte Biotechnology Holdings, Inc. (OTCQB: LIXT), announced ... trial of Lixte,s lead compound, LB‑100, is being conducted, has ... John S. Kovach , M.D., the founder and President of ... completed at a single site. Accrual of patients, however, was ...
(Date:1/23/2015)... 23, 2015 Gem Pharmaceuticals announced today that the ... into the Company,s Phase 2 clinical trial.  This open-label ... lead compound, GPX-150 (an investigational medication), in approximately 30 ... Logo - http://photos.prnewswire.com/prnh/20150123/170966LOGO ...
Breaking Medicine Technology:Harwood Feffer LLP Announces Investigation of Advaxis, Inc. 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 3Gem Pharmaceuticals Announces Enrollment of Initial Patients in its Phase 2 Clinical Trial to Assess the Efficacy and Safety of GPX-150 in Sarcoma Patients 2
Cached News: